Document:

Exhibit 10.2

 

Execution
Version

 

AMENDMENT
NO. 4 TO CREDIT AGREEMENT

 

AMENDMENT NO. 4 TO CREDIT
AGREEMENT, dated as of August 18, 2017 (this “Agreement”), by and among WABASH NATIONAL CORPORATION (the “Borrower”),
MORGAN STANLEY SENIOR FUNDING, INC. (“MSSF”), in its capacity as administrative agent (in such capacity, the
“Administrative Agent”), each Lender party or consenting hereto, and each of the other Credit Parties party
hereto.

 

RECITALS:

 

WHEREAS, reference is
hereby made to the Credit Agreement (as amended by that certain Amendment No. 1 to Credit Agreement dated as of April 25, 2013,
by and among the Borrower, each lender and each additional refinancing lender party or consenting thereto and MSSF, as administrative
agent, as amended by that certain Amendment No. 2 to Credit Agreement dated as of March 19, 2015, by and among the Borrower, each
lender and each additional refinancing lender party or consenting thereto and MSSF, as administrative agent, as amended by that
certain Amendment No. 3 to Credit Agreement dated as of February 24, 2017, by and among the Borrower, each lender and each additional
refinancing lender party or consenting thereto and MSSF, as administrative agent, and as further amended, supplemented or otherwise
modified from time to time immediately prior to the effectiveness of this Agreement, the “Credit Agreement”;
capitalized terms used but not defined herein having the meanings set forth in the Credit Agreement), dated as of May 8, 2012,
among the Borrower, the Lenders party thereto, and MSSF, as Administrative Agent;

 

WHEREAS, the Borrower
has notified the Administrative Agent that the Borrower intends to acquire Supreme Industries, Inc. ("Supreme")
pursuant to that certain Agreement and Plan of Merger dated as of August 8, 2017 by and among the Borrower, Redhawk Acquisition
Corporation ("Merger Sub") and Supreme, under which Merger Sub, a wholly-owned Subsidiary of the Borrower, will
merge with and into Supreme, with Supreme continuing as the surviving entity of such merger and a wholly-owned Subsidiary of the
Borrower (the "Proposed Acquisition");

 

WHEREAS, the Borrower
intends to finance the Proposed Acquisition by the issuance (either by private placement or an underwritten public sale) by the
Borrower of equity-linked (including, without limitation, convertible debt) or debt securities (the "Securities"),
and/or the incurrence of term loans or other similar credit facilities or any other debt financing (the "Acquisition Loans"),
generating aggregate proceeds of up to $325,000,000;

 

WHEREAS, to the extent
that any or all of the Securities or the Acquisition Loans are not issued or the proceeds thereof are not made available to the
Borrower in an aggregate of up to $300,000,000, the Borrower intends to incur a senior unsecured bridge credit facility in an aggregate
principal amount of up to $300,000,000 (the "Notes Bridge");

 

WHEREAS, the Borrower
has sought the consent of the Required Lenders to consummation of the Proposed Acquisition and incurrence of the Securities, Acquisition
Loans and/or Notes Bridge (collectively, the "Transactions") under the Loan Documents;

 

WHEREAS, the Borrower
has sought reciprocal consent from the lenders under its Revolving Credit Agreement (as amended, restated, modified or supplemented
from time to time) in respect of the consummation of the Transactions and to otherwise amend the Revolving Indebtedness Documents
in respect thereof (the “ABL Amendment”);

 

     

     

    

 

NOW, THEREFORE, in consideration
of the premises and agreements, provisions and covenants herein contained, the parties hereto hereby agree as follows:

 

		1.	Credit Document Amendments. The Credit Documents are hereby amended as follows:

 

		(a)	Section 1.1 of the Credit Agreement is amended by inserting the following new definitions
in their correct alphabetical order:

 

“ABL
Amendment” shall mean that certain Third Amendment to the Revolving Credit Agreement dated as of August 16, 2017, among
Wells Fargo Capital Finance, LLC, the lenders party thereto, the Borrower, certain Subsidiaries of the Borrower designated on the
signature pages thereto as borrowers and certain Subsidiaries of the Borrower designated on the signature pages thereto as guarantors.

 

“Acquisition
Loans” shall mean the term loans or other similar credit facilities or any other debt financing incurred by the Borrower.

 

“Ally
Financing Documents” shall mean that certain Inventory Loan and Security Agreement among Supreme Corporation, a Texas
corporation, Supreme Indiana Operations, Inc., a Delaware corporation, and Ally Financial Inc. and/or its Affiliates, and each
of other agreements, instruments and documents executed in connection therewith, as in effect on the Amendment No. 4 Effective
Date.

 

“Amendment
No. 4” shall mean Amendment No. 4 to this Agreement, dated as of August 18, 2017, among the Borrower, the other Credit
Parties party thereto, the Lenders party thereto, and the Administrative Agent.

 

“Amendment
No. 4 Effective Date” shall mean the “Effective Date” under and as defined in Amendment No. 4.

 

“Bridge
Facility” shall mean a senior unsecured bridge credit facility to be incurred by the Borrower in connection with the
Supreme Acquisition.

 

"Bridge
Facility Springing Maturity Date" has the meaning assigned to such term in the definition of “Maturity Date”.

 

“Merger
Sub” shall mean Redhawk Acquisition Corporation, a Delaware corporation, and a wholly-owned Subsidiary of the Borrower.

 

"Permitted
Inventory Financing" shall mean (a) the financing available under the Ally Financing Documents or (b) any financing entered
into by Supreme or one or more of its Subsidiaries in substitution of the financing under the Ally Financing Documents that is
substantially similar to the financing under the Ally Financing Documents in all material respects, as determined in the Administrative
Agent’s reasonable discretion, in each case, which shall be subject to a Permitted Inventory Financing Intercreditor Agreement
unless otherwise agreed by the Administrative Agent in its reasonable discretion.

 

“Permitted
Inventory Financing Intercreditor Agreement” means an Intercreditor Agreement entered into in connection with the Permitted
Inventory Financing among the Credit Parties, the Administrative Agent, the Revolving Collateral Agent and the lender providing
the Permitted Inventory Financing, in form and substance reasonably satisfactory to the Administrative Agent.

 

    	 	2	 

     

    

 

"Permitted
Inventory Financing Inventory" means (a) Inventory of Supreme Corporation, a Texas corporation, and Supreme Indiana Operations,
Inc., a Delaware corporation, the purchase of which is financed by Ally Financial Inc. or its Affiliates, pursuant to the terms
of the Ally Financing Documents (the “Ally Inventory”), or (b) Inventory of Supreme or one or more of its
Subsidiaries that is substantially similar to the Ally Inventory in all material respects, as determined in the Administrative
Agent’s reasonable discretion.

 

“Securities”
shall mean equity-linked (including, without limitation, convertible debt) or debt securities issued by the Borrower (either by
private placement or an underwritten public sale).

 

“Supreme”
shall mean Supreme Industries, Inc., a Delaware corporation.

 

“Supreme
Acquisition” shall mean the acquisition of Supreme by the Borrower and the merger of Merger Sub with and into Supreme,
with Supreme being the surviving entity of such merger and a wholly-owned Subsidiary of the Borrower, pursuant to the terms of
the Supreme Acquisition Agreement.

 

“Supreme
Acquisition Agreement” shall mean that certain Agreement and Plan of Merger dated as of August 8, 2017 by and among the
Borrower, Merger Sub and Supreme (without giving effect to any amendment modification, supplement, consent, waiver or request that
are materially adverse to the Lenders, unless consented to by the Administrative Agent (it being understood that any change in
the purchase price of the Supreme Acquisition shall be deemed to be materially adverse to the Lenders, except (i) any decrease
in the purchase price of 5% or less of the aggregate consideration payable in connection with the Supreme Acquisition shall not
be material and adverse to the interests of the Lenders, (ii) any increase in the purchase price shall not be materially adverse
to the Lenders so long as such increase is solely funded by (x) the cash proceeds from an issuance of common stock of the Borrower,
(y) consideration in the form of an issuance of common stock of the Borrower, or a combination thereof or
(z) other cash balances available to the Borrower, and (iii) any decreases in purchase price and (without duplication) decreases
in the cash portion of the purchase price shall not be deemed to be materially adverse to the Lenders so long as such purchase
price reduction shall reduce dollar-for-dollar the commitments in respect of the Bridge Facility)).

 

"Supreme
Acquisition Agreement Representations" means those representations and warranties made by Supreme in the Supreme Acquisition
Agreement that are material to the interests of the Lenders, but only to the extent that the Borrower or Merger Sub have the right
(determined without regard to notice requirements) to terminate the Borrower’s or Merger Sub's obligations under the Supreme
Acquisition Agreement or to decline to consummate the Supreme Acquisition, in each case, as a result of a breach of such representation
or warranty in the Supreme Acquisition Agreement.

 

“Supreme
Acquisition Conditions” shall mean "Supreme Acquisition Conditions" means the satisfaction or waiver by the
Agent of the following conditions precedent:

 

    	 	3	 

     

    

 

(a)          the
Supreme Acquisition shall have been consummated in accordance with the term of the Supreme Acquisition Agreement;

 

(b)          since
January 1, 2017, there has not been any "Company Material Adverse Effect"; solely for the purposes this clause (a) of
the definition of "Supreme Acquisition Conditions" means, (x) "Company Material Adverse Effect" means
a Material Adverse Effect (as hereinafter defined) on the Borrower; provided, that none of the following shall constitute, or shall
be considered in determining whether there has occurred a Company Material Adverse Effect: (i) any change or effect resulting from
changes in general economic, regulatory or business conditions in the United States generally or in world capital markets, so long
as such changes or effects do not adversely affect the Borrower and its Subsidiaries, taken as a whole, in a disproportionate manner
relative to other similarly situated participants in the industries or markets in which they operate, (ii) any change in general
economic conditions that affect the industries in which the Borrower and its Subsidiaries conduct their business, so long as such
changes or conditions do not adversely affect the Borrower and its Subsidiaries, taken as a whole, in a disproportionate manner
relative to other similarly situated participants in the industries or markets in which they operate, (iii) any outbreak of hostilities
or war (including acts of terrorism), natural disasters or other force majeure events, in each case in the United States or elsewhere,
so long as such events do not adversely affect the Borrower and its Subsidiaries, taken as a whole, in a disproportionate manner
relative to other similarly situated participants in the industries or markets in which they operate, (iv) any change or effect
that affects the commercial vehicle manufacturing industry generally (including regulatory changes affecting the commercial vehicle
manufacturing industry generally) so long as such changes or conditions do not adversely affect the Borrower and its Subsidiaries,
taken as a whole, in a disproportionate manner relative to other similarly situated participants in the industries or markets in
which they operate, (v) any change in the trading prices or trading volume of the Borrower’s capital stock, in the Borrower’s
credit rating or in any analyst's recommendations with respect to the Borrower, (vi) any failure by the Borrower to meet any published
or internally prepared earnings or other financial projections, performance measures or operating statistics (whether such projections
or predictions were made by the Borrower or independent third parties), (vii) any adoption, implementation, promulgation,
repeal, modification, reinterpretation or proposal of any rule, regulation, ordinance, order, protocol or any other applicable
law of or by any national, regional, state or local governmental entity in the United States or elsewhere in the world, so long
as such adoption, implementation, promulgation, repeal, modification, reinterpretation or proposal does not disproportionately
impact the Borrower and its Subsidiaries considered collectively as a single enterprise, relative to other industry participants,
(viii) any changes in GAAP or interpretations thereof so long as such changes do not adversely affect the Borrower and its Subsidiaries,
taken as a whole, in a disproportionate manner relative to other similarly situated participants in the industries or markets in
which they operate, (ix) the Borrower’s failure to maintain the listing of the shares on the NYSE MKT as a result of the
trading price of the shares (provided, that the facts and circumstances giving rise to such changes shall not be excluded under
this clause (ix)), (x) the compliance by the Borrower with the covenants set forth in Article VI of the Supreme Acquisition Agreement
or (xi) any change or effect resulting from the announcement or pendency of the Supreme Acquisition Agreement, the Offer (as defined
in the Supreme Acquisition Agreement) or the Supreme Acquisition; it being understood that the exceptions in clauses (v) and (vi)
shall not prevent or otherwise affect a determination that the underlying cause of any such change or failure referred to therein
(if not otherwise falling within any of the exceptions provided by clauses (i) through (iv) and (vii) through (xi) hereof) is or
will be reasonably likely to be a Company Material Adverse Effect; provided that for purposes of this definition, each capitalized
term shall have the meaning set forth in the Supreme Acquisition Agreement; and (y) "Material Adverse Effect" means with
respect to a specified Person, any change, effect, event, circumstance or occurrence with respect to the business, financial condition,
results of operations, properties, assets, liabilities or obligations of such Person or its Subsidiaries, that is, or would be
reasonably expected to have a material adverse effect on the current or future business, assets, properties, liabilities or obligations,
results of operations or financial condition of the Person and its Subsidiaries, taken as a whole, or on the ability of the Person
to perform in a timely manner its obligations under the Supreme Acquisition Agreement or consummate the transactions contemplated
by the Supreme Acquisition Agreement; provided that for purposes of this definition, each capitalized term shall have the meaning
set forth in the Supreme Acquisition Agreement;

 

    	 	4	 

     

    

 

(c)          each
of the Supreme Acquisition Agreement Representations and the Supreme Specified Representation shall be true, correct, and complete,
in all material respects (except that such materiality qualifier shall not be applicable to any representations and warranties
that already are qualified or modified by materiality in the text thereof);

 

(d)          the
Credit Parties shall have provided the documentation and other information with respect to Supreme and its Affiliates to the Lenders
at least three (3) business days prior to the closing of the Supreme Acquisition as has been reasonably requested in writing
at least ten (10) business days prior to the closing date by the Agent that are required by regulatory authorities under the applicable
"know-your-customer" and anti-money laundering rules and regulations, including the Patriot Act;

 

(e)          the
Administrative Agent shall have received a solvency and non-contravention certificate from the Chief Financial Officer of the Borrower
in substantially the form attached as Annex I to Amendment No. 4;

 

(e)          immediately
following the consummation of the Supreme Acquisition, Supreme shall have no material Indebtedness for borrowed money or preferred
equity other than Indebtedness permitted under the Supreme Acquisition Agreement;

 

(f)          the
Administrative Agent shall have received (i) GAAP audited consolidated balance sheets and related statements of income, stockholders'
equity and cash flows of Supreme for each of the fiscal years ending December 31, 2014, December 31, 2015 and December 31, 2016,
(ii) within 45 days after the end of each fiscal quarter of the 2017 fiscal year, unaudited consolidated balance sheets and related
statements of income and cash flows of Supreme for such fiscal quarter, for the period elapsed from the beginning of the 2017 fiscal
year to the end of such fiscal quarter and for the comparable periods of the preceding fiscal year (with respect to which the independent
auditors shall have performed an SAS 100 review), (iii) a pro forma consolidated and consolidating balance sheet and related statements
of income and cash flows for the Borrower, as well as pro forma levels of EBITDA, for the fiscal year ended December 31, 2016 and
for the four-quarter period most recently ended for which unaudited financial statements have been delivered pursuant to Section
9.1, in each case after giving effect to the consummation of the Supreme Acquisition and (iv) forecasts of the financial performance
of Borrower and its Subsidiaries (giving pro forma effect to the Supreme Acquisition) (x) on an annual basis, through 2021
and (y) on a quarterly basis, through 2018; provided that the Borrower’s and Supreme’s public filing of any required
financial statements with the SEC shall constitute delivery of such financial statements to the Administrative Agent; and

 

    	 	5	 

     

    

 

(g)          all
accrued costs, fees and expenses of the Administrative Agent (including reasonable and documented out-of-pocket legal fees and
expenses) payable in accordance with Section 13.5(a) of the Credit Agreement and, in the case of expenses, to the extent invoiced
or estimated not later than 1 Business Day prior to the consummation of the Supreme Acquisition, and other compensation due and
payable to the Administrative Agent and the Lenders shall have been paid by the Borrowers.

 

“Supreme
Completion Date” shall mean the date on which consummation of the Supreme Acquisition occurs.

 

“Supreme
Specified Representation” shall mean the representation and warranty set forth in Section 8.2(b)(ii) as it relates
to this Agreement, the Revolving Indebtedness Documents, the Permitted Convertible Notes Documents and the documents and agreement
evidencing the Permitted Inventory Financing.

 

		(b)	Section 1.1 of the Credit Agreement is amended by replacing the definition of “Applicable
ECF Percentage” with the following:

 

“Applicable
ECF Percentage” shall mean, for any Excess Cash Flow Period, (a) 50% if the Senior Secured Leverage Ratio as of
the last day of such Excess Cash Flow Period is greater than or equal to 2.75 to 1.00 and (b) 0% if the Senior Secured Leverage
Ratio as of the last day of such Excess Cash Flow Period is less than 2.75 to 1.00.”

 

		(c)	Section 1.1 of the
Credit Agreement is amended by replacing clause (ii) of the proviso to the definition of “Available Amount Basket”
with the following: “[reserved]”.

 

		(d)	Section 1.1 of the
Credit Agreement is amended by amending the Total Leverage Ratio test in clause (iii) of the proviso to the definition
of “Available Amount Basket” to “3.25 to 1.00”.

 

		(e)	Section 1.1 of the Credit Agreement is amended by replacing the definition of “Collateral”
with the following:

 

“Collateral”
shall mean all assets and interests in assets and proceeds thereof now owned or hereafter acquired by any Credit Party or any of
its Subsidiaries in or upon which a Lien is granted or purported to be granted by such Person in favor of the Administrative Agent,
the Collateral Agent or the Lenders under any of the Credit Documents; provided that notwithstanding anything to the contrary
in any of the Credit Documents, if the Permitted Inventory Financing Intercreditor Agreement is not entered into, the Permitted
Inventory Financing Inventory shall be deemed to be excluded from the definition of Collateral for all purposes under the Credit
Documents.

 

    	 	6	 

     

    

 

		(f)	Section 1.1 of the Credit Agreement is amended by amending the definition of “Consolidated
Net Income” by adding the following proviso to the end of such definition:

 

“;
provided further that solely for the purposes of determining the amount of Excess Cash Flow and the Available Amount Basket,
the net earnings (or loss) of Supreme and its Subsidiaries during any applicable period up to the date that is four full fiscal
quarters after the Supreme Completion Date shall be excluded from any such determination including such period.”

 

		(g)	Section. 1.1 of the Credit Agreement is amended by replacing the definition of “Extraordinary
Receipts” with the following:

 

““Extraordinary
Receipts” means any payments received by the Borrower or any of its Subsidiaries not in the ordinary course of business
(and not consisting of proceeds described in Section 5.2(a) of this Agreement) consisting of (a) proceeds of judgments,
proceeds of settlements or other consideration of any kind in connection with any cause of action, (b) indemnity payments (other
than to the extent such indemnity payments are (i) immediately payable to a Person that is not an Affiliate of the Borrower or
any of its Subsidiaries, (ii) received by the Borrower or any of its Subsidiaries as reimbursement for any payment previously made
to such Person or (iii) received pursuant to the indemnity provisions of the Supreme Acquisition Agreement), (c) any purchase price
adjustment (other than a working capital adjustment) received in connection with any purchase agreement (other than the Supreme
Acquisition Agreement), or at any other time, any purchase price adjustment (other than a working capital adjustment) in excess
of $1,000,000 in connection with any purchase agreement (other than the Supreme Acquisition Agreement), (d) tax refunds, and (e)
pension plan reversions”.

 

		(h)	Section 1.1 of the
Credit Agreement is amended by replacing the words “in Section 10.15” in the proviso to the definition of “GAAP”
with the following: “herein”.

 

		(i)	Section. 1.1 of the Credit Agreement is amended by amending the definition of “Maturity
Date” by adding the following proviso to the end of such definition:

 

“;
provided further, that if the Bridge Facility (and any Permitted Refinancing Indebtedness in respect thereof) is not converted,
redeemed, repurchased or refinanced in full on or before the date that is 15 days prior to the maturity date of the Bridge Facility
pursuant to one or more transactions permitted under this Agreement, such that the maturity date in respect of the Bridge Facility
(and any Permitted Refinancing Indebtedness in respect thereof) is not at least 91 days after the Maturity Date, the Maturity Date
shall be the date that is 15 days prior to the maturity date of the Bridge Facility (such date, the "Bridge Facility Springing
Maturity Date"); provided further, that no Bridge Facility Springing Maturity Date shall be deemed to occur if
on the Bridge Facility Springing Maturity Date and at all times following the Bridge Facility Springing Maturity Date until the
Bridge Facility (and any Permitted Refinancing Indebtedness in respect thereof, the maturity date of which is not at least 91 days
after the Maturity Date) is converted, redeemed, repurchased or refinanced in full, the Borrower maintains cash on the balance
sheet in an amount not less than the aggregate outstanding amount of all liabilities and Indebtedness owing in respect of the Bridge
Facility.”

 

    	 	7	 

     

    

 

		(j)	Section. 1.1 of the Credit Agreement is amended by replacing the words “shall mean
any Acquisition so long as:” in the definition of “Permitted Acquisition” with “shall mean (x) upon
the satisfaction or waiver by the Administrative Agent of the Supreme Acquisition Conditions, the Supreme Acquisition and (y) any
other Acquisition so long as:”.

 

		(k)	Section. 1.1 of the Credit Agreement is amended by replacing clause (f) of the definition
of “Permitted Acquisition” with “(f) [reserved]; and”.

 

		(l)	The definition of “Permitted Indebtedness” in Section. 1.1 of the Credit
Agreement is amended by:

 

		(i)	replacing “$200,000,000” in clause (q)(i)(A) in the definition of “Permitted
Indebtedness” with “$225,000,000”; and

 

		(ii)	replacing clause (g) of the definition with:

 

“(g)          Acquired
Indebtedness of Supreme outstanding as of the consummation of the Supreme Acquisition and permitted to remain outstanding under
the Supreme Acquisition Agreement, plus additional Acquired Indebtedness in an aggregate principal amount not to exceed $10,000,000
outstanding at any one time;”

 

		(iii)	deleting the word “and” at the end of clause (t) and adding new clauses (v),
(w), and (x) as follows:

 

“(v)          the
Securities and/or the Acquisition Loans, in an aggregate principal amount not to exceed $325,000,000 (provided that the amount
of the commitments in respect of the Bridge Facility shall have been reduced by a corresponding amount) and with a maturity date
no earlier than 91 days after the Maturity Date, so long as the proceeds thereof are used to (x) consummate the Supreme Acquisition
and pay fees and expenses in connection therewith or (y) repay such Indebtedness of the Credit Parties on or before the date that
is 15 Business Days following the date that the mandatory redemption, mandatory prepayment or similar feature is triggered under
the definitive documentation governing the Securities and/or Acquisition Loans as a result of the abandonment or termination of
the Supreme Acquisition or the Supreme Acquisition Agreement or expiration of a related outside date;

 

(w)          solely
to the extent the Securities and/or the Acquisition Loans are not issued or the proceeds not made available to the Borrower prior
to the consummation of the Supreme Acquisition in an aggregate amount of up to $300,000,000, a loan under the Bridge Facility in
an aggregate principal amount not to exceed $300,000,000, so long as (x) the proceeds thereof are used to consummate the Supreme
Acquisition and pay fees and expenses in connection therewith, and (y) the principal amount of Indebtedness outstanding under clause
(v) above and this clause (w) does not exceed $325,000,000 in the aggregate and any Permitted Refinancing Indebtedness
in respect of such Indebtedness under the Bridge Facility; and

 

(x)          Indebtedness
owing under the Permitted Inventory Financing.”

 

    	 	8	 

     

    

 

		(m)	The definition of “Permitted Liens” in Section. 1.1 of the Credit Agreement
is amended by deleting the word “and” at the end of clause (v) thereof and adding new clauses (x), (y)
and (z) to such definition as follows:

 

“(x)          Liens
on Collateral securing the Acquisition Loans, subject to an intercreditor agreement containing terms, taken as a whole, that are
at least as favorable to Administrative Agent and the Lenders as those terms contained in the Intercreditor Agreement, taken as
a whole;

 

(y)          Liens
securing the Permitted Inventory Financing solely on the Permitted Inventory Financing Inventory (it being understood and agreed
that if the Permitted Inventory Financing Intercreditor Agreement is not entered into, the Permitted Inventory Financing Inventory
shall be deemed to be excluded from the definition of Collateral for all purposes under the Credit Documents); and

 

(z)          Liens
on Collateral securing any Permitted Refinancing Indebtedness that refinances the Bridge Facility, subject to an intercreditor
agreement containing terms, taken as a whole, that are at least as favorable to the Administrative Agent and the Lenders as those
terms contained in the Intercreditor Agreement, taken as a whole.”

 

		(n)	The definition of “Permitted Refinancing Indebtedness” in Section. 1.1
of the Credit Agreement is amended by replacing the word “and”, immediately before clause (e), with “,”
and adding a new clause (f) at the end of the definition as follows:

 

“and
(f) in the case of the Refinancing Indebtedness relating to Indebtedness under the Bridge Facility, the terms of the agreements
evidencing such Refinancing Indebtedness ("New Financing Documents") shall not, without the consent of the Administrative
Agent (which consent shall not be unreasonably delayed or withheld), (i) be subject to terms and conditions other than customary
market terms and conditions for Indebtedness of such type, as determined in the good faith judgment of the Borrower, or (ii) have
a maturity date no earlier than 91 days after the Maturity Date”.

 

		(o)	Section 9.1(a) of the Credit Agreement is amended by adding “or” before clause
(B) thereof and deleting clause (C).

 

		(p)	Section 9.11 of the Credit Agreement is amended by replacing the fair market value threshold
for Real Property of “$1,000,000” with “$5,000,000”.

 

		(q)	Section 9.12 of the Credit Agreement is amended by replacing the fair market value threshold
for Real Property of “$1,000,000” with “$5,000,000”.

 

		(r)	Section 10.9 of the Credit Agreement is amended by replacing clause (f) with the
following new clauses (f) and (g):

 

“(f)          any
Subsidiary may make Restricted Payments to the Borrower or any other Subsidiary; provided that in the case of any such Restricted
Payment by a Subsidiary that is not a Wholly-Owned Subsidiary, such Restricted Payment is made to the Borrower or any of its Subsidiaries
and to each other owner of Equity Interests of such Subsidiary based on their relative ownership interests of the relevant class
of Equity Interests, and

 

    	 	9	 

     

    

 

(g)          in
addition to the Restricted Payments permitted in clauses (a) through (f) above, the Borrower may make other Restricted Payments
(i) in an aggregate amount taken together with all other Restricted Payments made pursuant to this Section 10.9(g)(i) not to exceed
$16,000,000 in the aggregate in any fiscal year and (ii) so long as the Total Leverage Ratio, on a pro forma basis, as of the last
Test Period at the end of which Section 9.1 Financials were required to have been delivered, would not exceed 2.00 to 1.00.”

 

		2.	Conditions to Effectiveness. This Agreement shall become effective on the first date (the
“Effective Date”), when, and only when, each of the following conditions have been satisfied (or waived) in
accordance with the terms therein:

 

		(a)	this Agreement shall have been executed and delivered by the Borrower, the other Credit Parties,
the Administrative Agent and the Lenders constituting Required Lenders;

 

		(b)	(A) all fees (including the Amendment Fee) and out-of-pocket expenses required to be paid or reimbursed
by the Borrower in connection with this Agreement shall have been paid or reimbursed and (B) all accrued interest and fees in respect
of the Transactions outstanding immediately prior to effectiveness of this Agreement shall have been paid; and

 

		(c)	the representations and warranties in Section 3 of this Agreement shall be true and correct
in all material respects as of the Effective Date.

 

		3.	Representations and Warranties. In order to induce Administrative Agent and Lenders to enter
into this Amendment, each Credit Party hereby makes each of the following representations and warranties to the Lenders at and
as of the date of the Effective Date:

 

		(a)	such Credit Party has the corporate or other organizational power and authority to execute, deliver
and carry out the terms and provisions of this Agreement and has taken all necessary corporate or other organizational action to
authorize the execution, delivery and performance of this Agreement;

 

		(b)	such Credit Party has duly executed and delivered this Agreement and this Agreement constitutes
the legal, valid and binding obligation of such Credit Party enforceable in accordance with its terms, except as the enforceability
thereof may be limited by bankruptcy, insolvency or similar laws affecting creditors’ rights generally and subject to general
principles of equity;

 

		(c)	neither the execution, delivery or performance by such Credit Party of this Agreement nor compliance
with the terms and provisions thereof nor the consummation of the transactions contemplated hereby will (a) contravene any material
provision of any applicable law, statute, rule, regulation, order, writ, injunction or decree of any court or governmental instrumentality,
(b) result in any breach of any of the terms, covenants, conditions or provisions of, or constitute a default under, or result
in the creation or imposition of (or the obligation to create or impose) any Lien upon any of the property or assets of such Credit
Party or any of the Subsidiaries (other than Permitted Liens) pursuant to the terms of any Material Contract of any Credit Party
or its Subsidiaries other than any such breach, default or Lien that could not reasonably be expected to result in a Material Adverse
Effect or (c) violate any provision of the certificate of incorporation, by-laws or other Organizational Document of such Credit
Party or any of its Subsidiaries;

 

    	 	10	 

     

    

 

		(d)	both immediately before and after giving effect to the Effective
Date and the Transactions, all representations and warranties made by each Credit Party contained in the Credit Agreement
and in the other Credit Documents shall be true and correct in all material respects (except that any representation and warranty
that is qualified as to “materiality” or “Material Adverse Effect” shall be true and correct in all respects)
with the same effect as though such representations and warranties had been made on and as of the Effective Date (except where
such representations and warranties expressly relate to an earlier date, in which case such representations and warranties shall
have been true and correct in all material respects (except that any representation and warranty that is qualified as to “materiality”
or “Material Adverse Effect” shall be true and correct in all respects) as of such earlier date); and

 

		(e)	no Default or Event of Default
shall exist on the Effective Date before or after giving effect to the effectiveness hereof and the consummation of the transactions
contemplated hereby.

 

		4.	Post-Effective Date Covenants.

 

		(a)	Promptly after consummation of the Supreme Acquisition, Supreme shall, and Borrowers shall cause
Redhawk to, comply with the provisions of Section 9.11 of the Credit Agreement within the time frames set forth therein.

 

		(b)	Within fifteen (15) days following the consummation of the Supreme Acquisition, the Borrower shall
deliver to Agent fully executed copies of all material documents executed in connection with the Indebtedness incurred to finance
the Supreme Acquisition.

 

		5.	Lender Acknowledgment. On the Effective Date, the Lenders party hereto, in their capacity
as “Term Lenders” under (and as defined in) the Intercreditor Agreement and MSSF, in its capacity as “Term Agent”
under (and as defined in) the Intercreditor Agreement, acknowledge and consent to the ABL Amendment (to the extent a fully executed
copy of which has been delivered to such Lenders and Agent) and each Credit Party’s execution thereof.

 

		6.	Amendment Fee. The Credit Parties hereby agree to pay to the Administrative Agent for the
ratable benefit of each Lender party to this Agreement, an amendment fee in an aggregate amount equal to 0.125% of the outstanding
principal amount of the Loans of all Lenders signatory to this Agreement (the "Amendment Fee"), which fee shall
be due and payable in full on the Effective Date.

 

		7.	Reaffirmation of the Credit Parties. Each Credit Party hereby consents to the amendment
of the Credit Agreement effected hereby and confirms and agrees that, notwithstanding the effectiveness of this Agreement, each
Credit Document to which such Credit Party is a party is, and the obligations of such Credit Party contained in the Credit Agreement,
this Agreement or in any other Credit Document to which it is a party are, and shall continue to be, in full force and effect and
are hereby ratified and confirmed in all respects, in each case as amended by this Agreement. For greater certainty and without
limiting the foregoing, each Credit Party hereby confirms that the existing security interests granted by such Credit Party in
favor of the Secured Parties pursuant to the Credit Documents in the Collateral described therein shall continue to secure the
obligations of the Credit Parties under the Credit Agreement and the other Credit Documents as and to the extent provided in the
Credit Documents.

 

    	 	11	 

     

    

 

		8.	Amendment, Modification and Waiver. This Agreement may not be amended, modified or waived
except in accordance with Section 13.1 of the Credit Agreement.

 

		9.	Entire Agreement. This Agreement, the Credit Agreement and the other Credit Documents constitute
the entire agreement among the parties hereto with respect to the subject matter hereof and thereof and supersede all other prior
agreements and understandings, both written and verbal, among the parties hereto with respect to the subject matter hereof. Except
as expressly set forth herein, this Agreement shall not by implication or otherwise limit, impair, constitute a waiver of, or otherwise
affect the rights and remedies of any party under, the Credit Agreement, nor alter, modify, amend or in any way affect any of the
terms, conditions, obligations, covenants or agreements contained in the Credit Agreement, all of which are ratified and affirmed
in all respects and shall continue in full force and effect. It is understood and agreed that each reference in each Credit Document
to the Credit Agreement, whether direct or indirect, shall hereafter be deemed to be a reference to the Credit Agreement as amended
hereby and that this Agreement is a Credit Document. This Agreement shall not constitute a novation of any amount owing under the
Credit Agreement and all amounts owing in respect of principal, interest, fees and other amounts pursuant to the Credit Agreement
and the other Credit Documents shall, to the extent not paid on or prior to the Effective Date, shall continue to be owing under
the Credit Agreement or such other Credit Documents until paid in accordance therewith.

 

		10.	GOVERNING LAW. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER
SHALL BE GOVERNED BY, CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. SECTIONS 13.13 AND
13.15 OF THE CREDIT AGREEMENT ARE HEREBY INCORPORATED BY REFERENCE INTO THIS AGREEMENT MUTATIS MUTANDIS AND SHALL APPLY
HERETO.

 

		11.	Severability. If any provision of this Agreement is held to be illegal, invalid or unenforceable,
the legality, validity and enforceability of the remaining provisions of this Agreement shall not be affected or impaired thereby.
The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other
jurisdiction.

 

		12.	Counterparts. This Agreement may be executed in one or more counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery by facsimile or other
electronic means of an executed counterpart of a signature page to this Agreement shall be effective as delivery of an original
executed counterpart of this Agreement.

 

[Remainder of Page Intentionally Blank]

 

    	 	12	 

     

    

 

IN WITNESS WHEREOF,
each of the undersigned has caused its duly authorized officer to execute and deliver this Agreement as of the date first written
above.

 

	 	WABASH NATIONAL CORPORATION, 
	 	as the Borrower
	 	 	 
	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Senior Vice President and Chief Financial

 Officer

 

[Signature Page to Amendment No. 4 to Term
Loan Credit Agreement]

 

     

     

    

 

	 	WABASH NATIONAL, L.P.,
	 	a Delaware limited partnership
	 	 	 
	 	By:	Wabash National Trailer Centers, Inc.,
	 	 	Its General Partner

 

	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Treasurer

 

	 	WABASH WOOD PRODUCTS, INC., (f/k/a WNC

 Cloud Merger Sub, Inc.),
	 	an Arkansas corporation
	 	 	 
	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Vice President and Treasurer

 

	 	TRANSCRAFT CORPORATION,
	 	a Delaware corporation
	 	 	 
	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Vice President and Treasurer

 

	 	WABASH NATIONAL TRAILER CENTERS, INC.,
	 	a Delaware corporation
	 	 	 
	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Treasurer

 

[Signature Page to Amendment No. 4 to Term
Loan Credit Agreement]

 

     

     

    

 

	 	CLOUD OAK FLOORING COMPANY, INC.,
	 	an Arkansas corporation
	 	 	 
	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Vice President and Treasurer

 

	 	CONTINENTAL TRANSIT CORPORATION,
	 	an Indiana corporation
	 	 	 
	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Treasurer

 

	 	FTSI DISTRIBUTION COMPANY, L.P.,
	 	a Delaware limited partnership
	 	 	 
	 	By:	Wabash National Trailer Centers, Inc.,
	 	 	Its General Partner

 

	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Treasurer

 

	 	NATIONAL TRAILER FUNDING, L.L.C.,
	 	a Delaware limited liability company
	 	 	 	             
	 	By:	Wabash National Trailer Centers, Inc.,
	 	 	Its Sole Member

 

	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Treasurer

 

[Signature Page to Amendment No. 4 to Term
Loan Credit Agreement]

 

     

     

    

 

	 	WABASH NATIONAL MANUFACTURING, L.P., 
	 	(f/k/a Wabash National Lease Receivables, L.P.), a 
	 	Delaware limited partnership
	 	 	 
	 	By:	Wabash National Corporation,
	 	 	Its General Partner

 

	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Senior Vice President and Chief 
	 	 	 	Financial Officer

 

	 	WABASH NATIONAL SERVICES, L.P., 
	 	a Delaware limited partnership
	 	 	 
	 	By:	Wabash National Trailer Centers, Inc.,
	 	 	Its General Partner

 

	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Treasurer

 

	 	WALKER GROUP HOLDINGS LLC, 
	 	a Texas limited liability company
	 	 	 
	 	By:	Wabash National, L.P.,
	 	 	Its Sole Member
	 	 	 
	 	By:	Wabash National Trailer Centers, Inc.,
	 	 	Its General Partner

 

	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Treasurer

 

[Signature Page to Amendment No. 4 to Term
Loan Credit Agreement]

 

     

     

    

 

	 	BULK SOLUTIONS LLC,
	 	a Texas limited liability company
	 	 	 
	 	By:	Walker Group Holdings LLC,
	 	 	Its Sole Member
	 	 	 
	 	By:	Wabash National, L.P.,
	 	 	Its Sole Member
	 	 	 
	 	By:	Wabash National Trailer Centers, Inc.,
	 	 	Its General Partner

 

	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Treasurer

 

	 	WALKER STAINLESS EQUIPMENT COMPANY LLC,
	 	a Delaware limited liability company
	 	 	 
	 	By:	Walker Group Holdings LLC,
	 		Its Sole Member
	 	 	 
	 	By:	Wabash National, L.P.,
	 		Its Sole Member
	 	 	 
	 	By:	Wabash National Trailer Centers, Inc.,
	 		Its General Partner

 

	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Treasurer

 

[Signature Page to Amendment No. 4 to Term
Loan Credit Agreement]

 

     

     

    

 

	 	BRENNER TANK LLC,
	 	a Wisconsin limited liability company
	 	 	 
	 	By:	Walker Group Holdings LLC,
	 	 	Its Sole Member
	 	 	 
	 	By:	Wabash National, L.P.,
	 	 	Its Sole Member
	 	 	 
	 	By:	Wabash National Trailer Centers, Inc.,
	 	 	Its General Partner

 

	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Treasurer

 

	 	GARSITE/PROGRESS LLC,
	 	a Texas limited liability company
	 	 	 
	 	By:	Walker Group Holdings LLC,
	 	 	Its Sole Member
	 	 	 
	 	By:	Wabash National, L.P.,
	 	 	Its Sole Member
	 	 	 
	 	By:	Wabash National Trailer Centers, Inc.,
	 	 	Its General Partner

 

	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Treasurer

 

[Signature Page to Amendment No. 4 to Term
Loan Credit Agreement]

 

     

     

    

 

	 	BRENNER TANK SERVICES LLC,
	 	a Wisconsin limited liability company
	 	 	 
	 	By:	Brenner Tank LLC,
	 	 	Its Sole Member
	 	 	 
	 	By:	Walker Group Holdings LLC,
	 	 	Its Sole Member
	 	 	 
	 	By:	Wabash National, L.P.,
	 	 	Its Sole Member
	 	 	 
	 	By:	Wabash National Trailer Centers, Inc.,
	 	 	Its General Partner

 

	 	By:	/s/ Jeffery L. Taylor
	 	 	Name:	Jeffery L. Taylor
	 	 	Title:	Treasurer

 

[Signature Page to Amendment No. 4 to Term
Loan Credit Agreement]

 

     

     

    

 

	 	MORGAN STANLEY SENIOR FUNDING, INC.,
	 	as Administrative Agent
	 	 	 
	 	By:	/s/ Chance Moreland
	 	 	Name:	Chance Moreland
	 	 	Title:	Authorized Signatory

 

[Signature Page to Amendment No. 4 to Term
Loan Credit Agreement]

 

     

     

    

 

	 	CATHAY BANK, as Lender
	 	 	 	 
	 	By:	/s/ Nancy A. Moore
	 	 	Name:	Nancy A. Moore
	 	 	Title:	Senior Vice President

 

[Signature Page to Amendment No. 4 to Term
Loan Credit Agreement]

 

     

     

    

 

ANNEX I

 

FORM OF SOLVENCY AND NON-CONTRAVENTION
CERTIFICATE

 

[_________], 2017

 

This Solvency and Non-Contravention
Certificate (this “Certificate”) is delivered pursuant to clause (e) of the definition of “Supreme
Acquisition Conditions” of the Credit Agreement, dated as of May 8, 2012 (as the same may be amended, amended and/or
restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among Wabash National
Corporation (the “Borrower”), Morgan Stanley Senior Funding, Inc., as the arranger and administrative agent
(the "Administrative Agent") for the lenders from time to time party thereto (the "Lenders"),
and each other credit party thereto. Capitalized terms used herein and not otherwise defined shall have the meanings set forth
in the Credit Agreement.

 

The undersigned, [________],
Chief Financial Officer of the Borrower, is familiar with the properties, businesses, assets and liabilities of the Borrower and
is duly authorized to execute this Certificate on behalf of the Borrower.

 

1.          Non-Contravention.
The undersigned hereby represents and warrants to the Lenders, on behalf of the Borrower and not in his or her individual capacity,
that each of the following representations and warranties shall be true, correct, and complete, in all material respects (except
that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified
by materiality in the text thereof), as of the date hereof: the performance by each Credit Party of the Credit Documents to which
it is a party does not materially conflict with, result in a breach of, or constitute (with due notice or lapse of time or both)
a default under (i) such Credit Party’s Organizational Documents, (ii) the Permitted Convertible Notes Indenture, (iii) the
Revolving Credit Agreement (to the extent the ABL Amendment is consummated on our prior to the date hereof), (iv) to the extent
applicable, the definitive documentation governing the Bridge Facility, (v) to the extent applicable, the definitive documentation
governing the Securities and/or Acquisition Loans or (vi) the definitive documents governing the Permitted Inventory Financing.

 

2.          Solvency.
The undersigned certifies, on behalf of the Borrower and not in his or her individual capacity, that (a) he has made such investigation
and inquiries as to the financial condition of the Borrower as the undersigned deems necessary and prudent for the purposes of
providing this Certificate, (b) the financial information, projections and assumptions which underlie and form the basis for
the representations made in this Certificate were made in good faith and were based on assumptions reasonably believed by the Borrower
to be fair in light of the circumstances existing at the time made and continue to be reasonably believed by the Borrower to be
fair as of the date hereof and (c) for purposes of providing this Certificate, the amount of contingent liabilities has been computed
as the amount that, in the light of all the facts and circumstances existing as of the time of such computation, represents the
amount that can reasonably be expected to become an actual or matured liability.

 

BASED ON THE FOREGOING,
the undersigned certifies, on behalf of the Borrower and not in his or her individual capacity, that, on the date hereof, both
before and after giving effect to the Supreme Acquisition (and the Indebtedness and other obligations incurred or to be incurred
in connection with the Supreme Acquisition), (a) the fair value of the assets of the Borrower and its Subsidiaries, on a consolidated
basis, at a fair valuation on a going concern basis, is greater than the total amount of liabilities, including, without limitation,
contingent liabilities, of the Borrower and its Subsidiaries, on a consolidated basis, (b) the present fair salable value of the
assets of the Borrower and its Subsidiaries, on a consolidated and going concern basis, is not less than the amount that will be
required to pay the probable liabilities (including contingent liabilities) of the Borrower and its Subsidiaries, on a consolidated
basis, on their debts as they become absolute and matured in the ordinary course of business, (c) the Borrower and its Subsidiaries,
on a consolidated basis, will be able to pay their debts and liabilities, as such debts and liabilities become absolute and matured
in the ordinary course of business and (d) the Borrower and its Subsidiaries, on a consolidated basis, will not have unreasonably
small capital with which to conduct the businesses in which they are engaged as such businesses are now conducted and are proposed
to be conducted following the Amendment No. 4 Effective Date.

 

     

     

    

 

IN WITNESS WHEREOF, the
undersigned has executed this Certificate on the date first above written.

 

	 	By:	 
	 	Name:	 
	 	Title:	Chief Financial OfficerEX-4.1

 Exhibit 4.1 

COHERUS BIOSCIENCES, INC. 

REGISTRATION RIGHTS AGREEMENT 

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made and entered into as of August 21, 2017, by and between
Coherus BioSciences, Inc., a Delaware corporation (the “Company”) and V-Sciences Investments Pte Ltd, a private limited Singapore company (“Temasek”)(the
“Purchaser”). 
 WHEREAS, the Company and the Purchaser are parties to that certain Stock Purchase Agreement dated as of
August 21, 2017 (the “Purchase Agreement”) pursuant to which the Company issued and sold to the Purchaser shares of its Common Stock, par value $0.0001 per share (the “Common Stock”); 

WHEREAS, the parties hereto desire to provide for, among other things, the grant of registration rights with respect to the Registrable
Securities (as defined below); 
 NOW, THEREFORE, in consideration of the mutual covenants and agreements contained in this Agreement, and
for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company and the Purchaser hereby agree as follows: 

1. DEFINITIONS. FOR PURPOSES OF THIS AGREEMENT:  

“Affiliate” means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled
by, or is under common control with such Person. 
 “Automatic Shelf Registration Statement” means an “automatic shelf
registration statement” as defined in Rule 405 promulgated under the Securities Act. 
 “Board of Directors” means the
board of directors of the Company (or any duly authorized committee thereof). 
 “Common Stock” has the meaning set forth
in the Recitals. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder. 
 “Excluded Registration” means (i) a registration on Form
S-8 (or similar successor form) relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; (ii) a registration on Form S-4 (or similar successor form) relating to an SEC Rule 145 transaction; or (iii) a registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that
are also being registered. 
 “FINRA” means the Financial Industry Regulatory Authority. 

“Form S-3” means such form under the Securities Act as in effect on the date hereof
or any registration form under the Securities Act subsequently adopted by the SEC that permits incorporation of substantial information by reference to other documents filed by the Company with the SEC. 

 “Holdback Period” has the meaning set forth in Subsection 2.10. 

“Holdback Extension” has the meaning set forth in Subsection 2.10. 

“Holders” means the Purchaser and any person holding Registrable Securities to whom the rights under this Agreement have been
transferred in accordance with Section 3.1 hereof. 
 “Indemnified Party” has the meaning set
forth in Subsection 2.8(c). 
 “Indemnifying Party” has the meaning set forth in Subsection 2.8(c). 

“Initial Closing Date” shall have the meaning set forth in the Purchase Agreement. 

“Initial Shares” shall have the meaning set forth in the Purchase Agreement. 

“Person” means any individual, corporation, partnership, trust, limited liability company, association or other entity. 

“Prospectus” means the prospectus related to any Registration Statement (whether preliminary or final or any prospectus
supplement), including post-effective amendments, and all materials incorporated by reference in such prospectus. 
 “Purchase
Agreement” has the meaning set forth in the Recitals. 
 “Purchase Price” shall have the meaning set forth in the
Purchase Agreement. 
 “Registrable Securities” means (i) any shares of Common Stock acquired pursuant to the Purchase
Agreement and (ii) shares of Common Stock issued as a dividend or distribution with respect to, or in exchange for or in replacement of, the shares referenced in (i) above or in connection with a combination of shares, recapitalization,
merger, consolidation or other reorganization; provided, that Registrable Securities held by any Holder will cease to be Registrable Securities, (A) when they have been sold to or through a broker or dealer or underwriter in a public
distribution or in a public securities transaction (including pursuant to an effective Registration Statement or pursuant to Rule 144 of the Securities Act), (B) when they have been sold in a transaction in which the transferor’s rights under
this Agreement are not validly assigned in accordance with this Agreement, (C) when they have been repurchased by the Company or (D) with respect to each holder of Registrable Securities, when such holder has satisfied all holding periods
under Rule 144 under the Securities Act and all of the Registrable Securities held by such holder may be sold under Rule 144(b)(1)(i) without limitation under any of the other requirements of Rule 144. 

“Registration Statement” means any registration statement filed pursuant to the Securities Act. 

“SEC” means the Securities and Exchange Commission. 

  
 2 

 “SEC Rule 144” means Rule 144 promulgated by the SEC under the Securities Act.

 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 “Selling Holder Counsel” has the meaning set forth in Subsection 2.6. 

“Selling Expenses” means all underwriting discounts, selling commissions, and stock transfer taxes applicable to the sale of
Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements of the Selling Holder Counsel borne and paid by the Company as provided in Subsection 2.6. 

“Shelf Registration” means a registration of securities pursuant to a Registration Statement filed with the SEC in accordance
with and pursuant to Rule 415 promulgated under the Securities Act. 
 “Shelf Registration Statement” has the meaning set
forth in Subsection 2.1(a) hereof. 
 “Subsequent Closing Date” shall have the meaning set forth in the Purchase
Agreement. 
 “Subsequent Shares” shall have the meaning set forth in the Purchase Agreement. 

“Suspension Period” has the meaning set forth in Subsection 2.1(b). 

“Underwriter” means the underwriter, placement agent or other similar intermediary participating in an Underwriting. 

“Underwriting” of securities means a public offering of securities registered under the Securities Act in which an
underwriter, placement agent or other similar intermediary participates in the distribution of such securities. 
 “WKSI”
means a “well-known seasoned issuer” as defined in Rule 405 under the Securities Act. 

  
 3 

 2. REGISTRATION RIGHTS. The Company covenants and agrees as follows: 

2.1 Shelf Registration and Suspension Periods. 

(a) Shelf Registration. 

(i) The Company shall prepare and, no later than the 40th day following each of (a) the Initial Closing Date, file with the SEC, one or
more registration statements covering the resale and distribution of all of the Initial Shares and (b) the Subsequent Closing Date, file with the SEC, one or more registration statements covering the resale and distribution of all of the
Subsequent Shares (whether singular or plural, the “Shelf Registration Statement”). The Shelf Registration Statement shall be on Form S-3 (if the Company is eligible to use Form S-3) or another appropriate form permitting registration of the Registrable Securities for resale by the Holders. The Company shall use its commercially reasonable efforts to cause the Shelf Registration Statement
to become effective as soon as practicable (and in any event within 100 days after its filing), and, once, effective, the Company shall use its commercially reasonable efforts to maintain the effectiveness of such Shelf Registration Statement until
the earlier of (i) the fourth anniversary of the Initial Closing Date with respect to the Shelf Registration Statement covering the Initial Shares and the Subsequent Closing Date with respect to the Shelf Registration Statement covering the
Subsequent Shares or (ii) the date all Registrable Securities purchased by the Purchaser may be sold under SEC Rule 144, without volume or manner-of-sale
restrictions (the “Effective Period”). The “Plan of Distribution” section of such Shelf Registration Statement, as it relates to the Holders, shall be in substantially the form attached hereto as
Exhibit A. The Shelf Registration Statement may include a primary registration initiated by the Company and may be a secondary registration requested by other holders of the Company’s securities; provided, that
the Company shall identify the Holders and include all Registrable Securities held by such Holders in the Shelf Registration Statement (unless the Holders of the Registrable Securities otherwise instruct the Company in writing). The Company shall be
required to comply with its obligations set forth herein relating the Shelf Registration Statement, including the deadlines contemplated hereby, whether or not a registration is initiated by the Company or requested by other holders of the
Company’s securities. 
 (ii) From and after the date that the Shelf Registration Statement is initially effective, as promptly as is
practicable after receipt of a request from a Holder, and in any event within (x) ten (10) days after the date such request is received by the Company or (y) if a request is so received during a Suspension Period, five (5) days after
the expiration of such Suspension Period, the Company shall take all necessary action to cause the requesting Holder to be named as a selling securityholder in the Shelf Registration Statement and the related Prospectus in such a manner as to permit
such Holder to deliver such Prospectus in connection with sales of such Registrable Securities to the purchasers thereof in accordance with applicable law, which action may include: (A) if required by applicable law, filing with the SEC a
post-effective amendment to the Shelf Registration Statement; (B) preparing and, if required by applicable law, filing a supplement or supplements to the related Prospectus or a supplement or amendment to any document incorporated therein by
reference; (C) filing any other required document; or (D) with respect to a post-effective amendment to the Shelf Registration Statement that is not automatically effective, using its reasonable best efforts to cause such post-effective
amendment to be declared or to otherwise become effective under the Securities Act as promptly as is practicable; provided that: (A) if the Shelf Registration Statement is not an Automatic Shelf Registration Statement and the Company has
already filed a post-effective amendment to the Shelf Registration Statement during the calendar quarter in which such filing would otherwise be required to be made, the Company may delay such filing until the tenth (10th) day of the following
calendar quarter; and (B) if such request is delivered during a Suspension Period, the Company shall so inform the Holder delivering such request and shall take the actions set forth above upon expiration of the Suspension Period in accordance
with Subsection 2.1(b). Notwithstanding anything to the contrary, the Company shall not be obligated to initiate an underwritten takedown offering from the Shelf Registration Statement upon a request of a Holder unless such Holder agrees to
reimburse the reasonable fees and expenses of the Company in connection with such underwritten takedown; provided, if the Company furnishes to Holders requesting an underwritten takedown offering pursuant to this Subsection 2.1(a)(ii) a
certificate signed by the Company’s chief executive officer stating that in the good faith judgment of the Company’s Board of Directors it would be materially detrimental to the Company and its stockholders to initiate such an underwritten
takedown because such action would (i) materially interfere with a significant acquisition, corporate reorganization, or other similar transaction involving the Company; (ii) require premature disclosure of material information that the
Company has a bona fide business purpose for preserving as confidential; or (iii) render the Company unable to comply with requirements under the Securities Act or Exchange Act, then the Company shall have the right to defer taking such action.

  
 4 

 (b) Suspension Periods. Upon written notice to the Holders of Registrable Securities,
(x) the Company shall be entitled to suspend, for a period of time, the use of any Registration Statement or Prospectus if the Board of Directors determines in its good faith judgment, after consultation with counsel, that the Registration
Statement or any Prospectus may contain an untrue statement of a material fact or omits any fact necessary to make the statements in the Registration Statement or Prospectus not misleading and (y) the Company shall not be required to amend or
supplement the Registration Statement, any related Prospectus or any document incorporated therein by reference if the Board of Directors determines in its good faith judgment, after consultation with counsel, that such amendment or supplement would
reasonably be expected to have a material adverse effect on any proposal or plan of the Company to effect a merger, acquisition, disposition, financing, reorganization, recapitalization or similar transaction, in each case that is material to the
Company (in case of each clause (x) and (y), a “Suspension Period”); provided that (A) the duration of all Suspension Periods may not exceed one hundred and twenty (120) days in the aggregate in any 12-month period and (B) the Company shall use its commercially reasonable efforts to amend or supplement the Registration Statement and/or Prospectus to correct such untrue statement or omission as soon as
reasonably practicable, but in no event shall any single suspension period exceed forty five (45) days. 
 (c) Secondary
Offering. If at any time the SEC takes the position that the offering of some or all of the Registrable Securities in a Registration Statement are not eligible to be made as a secondary offering, the Company shall use reasonable best efforts to
persuade the SEC that the offering contemplated by the Registration Statement is a bona fide secondary offering. In the event that the SEC refuses to alter its position, the Company shall (i) remove from the Registration Statement such portion
of the Registrable Securities (the “Cut Back Shares”) and/or (ii) agree to such restrictions and limitations on the registration and resale of the Registrable Securities as the SEC may require to assure that the Registration
Statement is deemed a secondary offering (collectively, the “SEC Restrictions”); provided, however, that the Company shall not agree to name any Holder as an “underwriter” in such Registration Statement without the prior
written consent of such Holder. Any cut-back imposed pursuant to this Section 2.1(c) shall be allocated among the Holders on a pro rata basis in accordance with the number of shares that such Holders have
requested to be included in such Registration Statement, unless the SEC Restrictions otherwise require or provide or the participating Holders otherwise agree. From and after the date that the Company is able to effect the registration of such Cut
Back Shares in accordance with any SEC Restrictions, all of the provisions of this Section 2.1 shall again be applicable to such Cut Back Shares. 

  
 5 

 2.2 Piggyback Registration. 

(a) If, prior to the effectiveness of the Shelf Registration Statement contemplated by Subsection 2.1, the Company proposes to register
(including, for this purpose, a registration for stockholders other than the Holders) any of its Common Stock under the Securities Act in connection with the public offering of such securities solely for cash for its own account (other than in an
Excluded Registration) and the registration form to be used may be used for the registration of Registrable Securities (a “Piggyback Registration”), the Company shall, at such time, promptly give each Holder written notice of such
proposed Piggyback Registration and, if within fifteen (15) calendar days after the date of such notice any such Holder shall so request in writing, the Company shall, if the Company has not filed the Shelf Registration Statement contemplated
by Subsection 2.1, cause to be included all of the Registrable Securities that each such Holder has requested to be included in such registration. 

(b) The Company shall not be required to register any Registrable Securities pursuant to this Subsection 2.2 that are eligible for
resale pursuant to Rule 144 promulgated under the Securities Act without volume limitation or that are the subject of a then effective Registration Statement. 

(c) If there is not an effective Registration Statement covering all of the Registrable Securities during the Effective Period, the Company
may file a Registration Statement with the SEC to register equity securities of the Company to be sold on a primary basis, provided that the Company does not sell any such equity securities until there is an effective Registration Statement
covering all of the Registrable Securities. 
 (d) The Company shall have the right to terminate or withdraw any registration initiated by
it under this Subsection 2.2 before the effective date of such registration, whether or not any Holder has elected to include Registrable Securities in such registration. The expenses (other than Selling Expenses) of such withdrawn
registration shall be borne by the Company in accordance with Subsection 2.6. For the avoidance of doubt, the managing underwriter or underwriters shall be selected by the Company. 

2.3 Underwriting Requirements. In connection with any offering involving an underwritten offering of shares of the Company’s Common
Stock pursuant to Subsection 2.2, the Company shall not be required to include any of the Holders’ Registrable Securities in such underwriting unless the Holders accept the terms of the underwriting as agreed upon between the Company and
its underwriters, and then only in such quantity as the underwriters in their sole discretion determine will not jeopardize the success of the offering by the Company. If the total number of securities, including Registrable Securities, requested by
stockholders to be included in such offering exceeds the number of securities that the underwriters in their reasonable discretion determine is compatible with the success of the offering, then the Company shall include in the offering the
securities requested to be included therein by the holders requesting such offering and the Registrable Securities requested to be included in such offering, which, in the opinion of the underwriters, can be sold without jeopardizing the success of
the offering, pro rata among the holders of such securities and the Holders of the Registrable Securities on the basis of the number of shares of Common Stock owned by each such holder. 

  
 6 

 2.4 Obligations of the Company. Whenever required under this
Section 2 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 

(a) in the case of the Shelf Registration Statement, prepare and file with the SEC a Registration Statement with respect to such Registrable
Securities and use its commercially reasonable efforts to cause such Registration Statement to become effective and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such Registration Statement
effective in accordance with Subsection 2.1(a) for so long as there are Registrable Securities outstanding; 
 (b) prepare and file
with the SEC such amendments and supplements to such Registration Statement, and the prospectus used in connection with such Registration Statement, as may be necessary to comply with the Securities Act in order to enable the disposition of all
securities covered by such Registration Statement; 
 (c) furnish to the selling Holders such numbers of copies of a prospectus, including a
preliminary prospectus, as required by the Securities Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities; 

(d) provide counsel to the Holders a reasonable opportunity to review and comment upon any Registration Statement and any Prospectus or
prospectus supplements; 
 (e) if requested by any participating Holder, promptly include in a Prospectus supplement or amendment such
information as the Holder may reasonably request, including in order to permit the intended method of distribution of such securities, and make all required filings of such Prospectus supplement or such amendment as soon as reasonably practicable
after the Company has received such request; 
 (f) use its commercially reasonable efforts to register and qualify, or obtain an exemption
from registration or qualification for the securities covered by such registration statement under such other securities or blue-sky laws of such jurisdictions as shall be reasonably requested by the selling
Holders; provided that the Company shall not be required to qualify to do business or to file a general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction
and except as may be required by the Securities Act; 
 (g) in the case of an underwritten offering, use its commercially reasonable efforts
to obtain a “comfort” letter or letters, dated as of such date or dates as the managing underwriters reasonably request, from the Company’s independent public accountants in customary form and covering such matters of the type
customarily covered by “comfort” letters as any managing underwriter reasonably requests; 
 (h) in the case of an underwritten
offering, furnish, at the request of any managing underwriter for such offering an opinion with respect to legal matters and a negative assurance letter with respect to disclosure matters, dated as of each closing date of such offering of counsel
representing the Company for the purposes of such registration, addressed to the underwriters, covering such matters with respect to the registration in respect of which such opinion and letter are being delivered as the underwriters, may reasonably
request and are customarily included in such opinions and negative assurance letters; 

  
 7 

 (i) in the case of an underwritten offering, use its commercially reasonable efforts to
cooperate and assist in any filings required to be made with FINRA and in the performance of any due diligence investigation by any underwriter and its counsel (including any “qualified independent underwriter,” if applicable) that is
(A) required or requested by FINRA in order to obtain written confirmation from FINRA that FINRA does not object to the fairness and reasonableness of the underwriting terms and arrangements (or any deemed underwriting terms and arrangements)
relating to the resale of Registrable Securities pursuant to the Shelf Registration Statement, including, without limitation, information provided to FINRA through its Public Offering system or (B) required to be retained in accordance with the
rules and regulations of FINRA; 
 (j) if requested by the managing underwriters, if any, or by any Holder of Registrable Securities being
sold in an underwritten offering, promptly incorporate in a Prospectus supplement or post-effective amendment to the Registration Statement such information as the managing underwriters, if any, or such Holders indicate relates to them or that they
reasonably request be included therein and make appropriate members of management available to meeting with potential investors in the offering; 

(k) cause the Registrable Securities covered by such Registration Statement to be registered with or approved by such other governmental
agencies or authorities, as may be reasonably necessary by virtue of the business and operations of the Company to enable the seller or sellers of Registrable Securities to consummate the disposition of such Registrable Securities; 

(l) in the event of any underwritten offering, enter into and perform its obligations under an underwriting agreement, in usual and customary
form, with the underwriter(s) of such offering; 
 (m) in the event of the issuance or threatened issuance of any stop order suspending the
effectiveness of a Registration Statement, or of any order suspending or preventing the use of any related Prospectus or suspending the qualification of any Registrable Securities included in such Registration Statement for sale in any jurisdiction,
use its commercially reasonable efforts promptly to (i) prevent the issuance of any such stop order, and in the event of such issuance, to obtain the withdrawal of such order and (ii) obtain, at the earliest practicable date, the
withdrawal of any order suspending or preventing the use of any related Prospectus or suspending qualification of any Registrable Securities included in such Registration Statement for sale in any jurisdiction; 

(n) use its commercially reasonable efforts to cause all such Registrable Securities covered by such Registration Statement to be listed on
each securities exchange and trading system (if any) on which similar securities issued by the Company are then listed; 
 (o) provide a
transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and provide a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration; 

  
 8 

 (p) promptly make available for inspection by the selling Holders, any managing underwriter(s)
participating in any disposition pursuant to such Registration Statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling Holders, all financial and other records, pertinent corporate
documents, and properties of the Company, and cause the Company’s officers, directors, employees, and independent accountants to supply all oral or written information reasonably requested by any such seller, underwriter, attorney, accountant,
or agent, in each case, as necessary or advisable to verify the accuracy of the information in such Registration Statement and to conduct appropriate due diligence in connection therewith; 

(q) notify each selling Holder, promptly after the Company receives notice thereof, of the time when such Registration Statement has been
declared effective or a supplement to any prospectus forming a part of such Registration Statement has been filed; 
 (r) notify each
selling Holder at any time when a Prospectus relating to the applicable Registration Statement is required to be delivered under the Securities Act: (i) as promptly as practicable upon discovery that, or upon the happening of any event as a
result of which, such Registration Statement, or the Prospectus relating to such Registration Statement, or any document incorporated or deemed to be incorporated therein by reference contains an untrue statement of a material fact or omits any fact
necessary to make the statements in the Registration Statement, the Prospectus relating thereto not misleading or otherwise requires the making of any changes in such Registration Statement, Prospectus, or document, and, at the request of any such
Holder and subject to the Company’s ability to declare Suspension Periods pursuant to Subsection 2.1(b), the Company shall promptly prepare a supplement or amendment to such Prospectus, furnish a reasonable number of copies of such supplement
or amendment to each such seller of such Registrable Securities, and file such supplement or amendment with the SEC so that, as thereafter delivered to the purchasers of such Registrable Securities, such Prospectus as so amended or supplemented
shall not contain an untrue statement of a material fact or omit to state any fact necessary to make the statements therein not misleading, (ii) as promptly as practicable after the Company becomes aware of any request by the SEC or any Federal
or state governmental authority for amendments or supplements to a Registration Statement or related Prospectus covering Registrable Securities or for additional information relating thereto, (iii) as promptly as practicable after the Company
becomes aware of the issuance or threatened issuance by the SEC of any stop order suspending or threatening to suspend the effectiveness of a Registration Statement covering the Registrable Securities or (iv) as promptly as practicable after
the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any Registrable Security for sale in any jurisdiction, or the initiation or threatening of any proceeding for such
purpose; and 
 (s) after such Registration Statement becomes effective, notify each selling Holder of any request by the SEC that the
Company amend or supplement such registration statement or prospectus. 
 (t) if the Company files an Automatic Shelf Registration Statement
covering any Registrable Securities, use its best efforts to remain a WKSI (and not become an ineligible issuer (as defined in Rule 405 under the Securities Act)) during the period during which such Automatic Shelf Registration Statement is required
to remain effective; 

  
 9 

 (u) if the Company does not pay the filing fee covering the Registrable Securities at the time
an Automatic Shelf Registration Statement is filed, pay such fee at such time or times as the Registrable Securities are to be sold; and 

(v) if the Automatic Shelf Registration Statement has been outstanding for at least three (3) years, at the end of the third year, refile
a new Automatic Shelf Registration Statement covering the Registrable Securities, and, if at any time when the Company is required to re-evaluate its WKSI status the Company determines that it is not a WKSI,
use its best efforts to refile the Shelf Registration Statement on Form S-3 and, if such form is not available, on another appropriate form permitting registration of the Registrable Securities for resale
by the Holders, and keep such Registration Statement effective during the period during which such Registration Statement is required to be kept effective. 

2.5 Furnish Information. It shall be a condition precedent to the obligations of the Company to take any action pursuant to this
Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of
disposition of such securities as is reasonably required to effect the registration of such Holder’s Registrable Securities. 
 2.6
Expenses of Registration. All expenses (other than Selling Expenses) incurred in connection with registrations, filings, or qualifications pursuant to Section 2, including all registration, filing, and qualification
fees; printers’ and accounting fees; fees and disbursements of counsel for the Company shall be borne and paid by the Company; provided, however, that the Company shall not be required to pay for any expenses of any registration
effected pursuant to Subsection 2.1 if the only securities to be included in such registration are Registrable Securities and the registration is withdrawn before effectiveness at the request of the Holders of a majority of the Registrable
Securities to be registered. Furthermore, in the event that a withdrawal by the Holders is based upon material adverse information relating to the Company that is different from the information known or available to the Holders on the date of this
Agreement, the Holders shall not bear the registration expenses for such registration. All Selling Expenses relating to Registrable Securities registered pursuant to this Section 2 shall be borne and paid by the Holders pro
rata on the basis of the number of Registrable Securities registered on their behalf. All other expenses related to the Shelf Registration Statement shall be borne and paid by the party that incurs such expense. 

2.7 Delay of Registration. No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any
registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

  
 10 

 2.8 Indemnification. If any Registrable Securities are included in a Registration
Statement under this Section 2: 
 (a) To the extent permitted by law, the Company will indemnify each Holder,
each of its officers, directors, employees, agents, partners, legal counsel, and accountants, and each person controlling such Holder within the meaning of Section 15 of the Securities Act, with respect to which registration, qualification, or
compliance has been effected pursuant to this Section 2, and each underwriter, if any, and each person who controls any underwriter within the meaning of Section 15 of the Securities Act, against all expenses, claims,
losses, damages, or liabilities (or actions, proceedings, or settlements in respect thereof) arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any registration statement, prospectus
(preliminary or final), offering circular, or other document (including any related registration statement, free writing prospectus, notification, or the like), or any amendment or supplement thereto, incident to any such registration,
qualification, or compliance, or arising out of or based on any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they
were made, not misleading, or arising out of or based on any violation by the Company of the Securities Act or any rule or regulation promulgated under the Securities Act or any other federal, state or common law rule or regulation applicable to the
Company in connection with any such registration, qualification, or compliance, and the Company will promptly reimburse each such Holder, each of its officers, directors, employees, agents, partners, legal counsel, and accountants, and each person
controlling such Holder, each such underwriter and each person who controls any such underwriter, for any legal and any other expenses reasonably incurred in connection with investigating, preparing, defending, or settling any such claim, loss,
damage, liability, or action, as such expenses are incurred, provided that the Company will not be liable in any such case to the extent that any such claim, loss, damage, liability, or expense arises out of or is based on any untrue statement or
omission or alleged untrue statement or omission, made in reliance upon and in strict conformity with written information furnished to the Company by such Holder, controlling person, or underwriter and stated to be specifically for use therein. It
is agreed that the indemnity agreement contained in this Section 2.8(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability, or action if such settlement is effected without the consent
of the Company (which consent shall not be unreasonably withheld). 
 (b) To the extent permitted by law, each Holder will, severally and
not jointly, if Registrable Securities held by such Holder are included in the securities as to which such registration, qualification, or compliance is being effected, indemnify the Company, each of its directors, officers, partners, legal counsel,
and accountants, and each underwriter, if any, of the Company’s securities covered by such a registration statement, each person who controls the Company or such underwriter within the meaning of Section 15 of the Securities Act, and each
other such Holder, each of their officers, directors, and partners, and each person controlling such Holder within the meaning of Section 15 of the Securities Act, against all claims, losses, damages, and liabilities (or actions in respect
thereof) arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any such registration statement, free writing prospectus, prospectus (preliminary or final), offering circular, or other document,
or any omission (or alleged omission) to state therein a material fact required to be stated therein, in light of the circumstances in which they were made, or necessary to make the statements therein not misleading, and will promptly reimburse the
Company and such Holders, directors, officers, partners, legal counsel, and accountants, persons, underwriters, or control persons for any legal or any other expenses reasonably incurred in connection with investigating or defending any such claim,
loss, damage, liability, or action, as such expenses are incurred, in each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such registration statement,
prospectus, offering circular, or other document in reliance upon and in strict conformity with written information furnished to the Company by such Holder and stated to be specifically for use therein, provided, however, that the obligations of
such Holder hereunder shall not apply to amounts paid in settlement of any such claims, losses, damages, or liabilities (or actions in respect thereof) if such settlement is effected without the consent of such Holder (which consent shall not be
unreasonably withheld); and provided that that in no event shall any indemnity under this Section 2.8(b) exceed the net proceeds received by such Holder in such offering. 

  
 11 

 (c) Each party entitled to indemnification under this Section 2.8 (the
“Indemnified Party”) shall give notice to the party required to provide indemnification (the “Indemnifying Party”) promptly after such Indemnified Party has actual knowledge of any claim as to which indemnity may be
sought, and shall permit the Indemnifying Party to assume the defense of any such claim or any litigation resulting therefrom, provided that counsel for the Indemnifying Party, who shall conduct the defense of such claim or litigation, shall be
approved by the Indemnified Party (whose approval shall not unreasonably be withheld), and the Indemnified Party may participate in such defense at such party’s expense, and provided further that the failure of any Indemnified Party to give
notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Section 2.8 unless the failure to give such notice is materially prejudicial to an Indemnifying Party’s ability to defend
such action. No Indemnifying Party, in the defense of any such claim or litigation, shall, except with the consent of each Indemnified Party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional
term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect to such claim or litigation. Each Indemnified Party shall furnish such information regarding itself or the claim in question as
an Indemnifying Party may reasonably request in writing and as shall be reasonably required in connection with the defense of such claim and litigation resulting therefrom. 

(d) If the indemnification provided for in this Section 2.8 is held by a court of competent jurisdiction to be
unavailable to an Indemnified Party with respect to any claim, loss, damage, liability, or expense referred to therein, then the Indemnifying Party, in lieu of indemnifying such Indemnified Party hereunder, shall contribute to the amount paid or
payable by such Indemnified Party as a result of such claim, loss, damage, liability, or expense in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party on the one hand and the Indemnified Party on the other in
connection with the statements or omissions that resulted in such claim, loss, damage, liability, or expense, as well as any other relevant equitable considerations. The relative fault of the Indemnifying Party and of the Indemnified Party shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact related to information supplied by the Indemnifying Party or by the Indemnified Party and the
parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission. The Company and the Holders agree that it would not be just and equitable if contribution pursuant to this
Section 2.8 were based solely upon the number of entities from whom contribution was requested or by any other method of allocation which does not take account of the equitable considerations referred to above. In no event
shall any contribution by a Holder under this Section 2.8 exceed the net proceeds received by such Holder in such offering. 

  
 12 

 (e) The amount paid or payable by an Indemnified Party as a result of the losses, claims,
damages, and liabilities referred to above in this Section 2.8 shall be deemed to include any legal or other expenses reasonably incurred by such Indemnified Party in connection with investigating or defending any such
action or claim, subject to the provisions of Section 2.8(c). No person guilty of fraudulent misrepresentation (within the meaning of the Securities Act) shall be entitled to contribution from any person who was not guilty
of such fraudulent misrepresentation. 
 (f) Notwithstanding the foregoing, to the extent that the provisions on indemnification and
contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

(g) The obligations of the Company and Holders under this Section 2.8 shall survive the completion of any offering
of Registrable Securities in a registration statement. 
 2.9 Reports Under Exchange Act. With a view to making available to the
Holders the benefits of SEC Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration, the Company shall: 

(a) make and keep available adequate current public information, as those terms are understood and defined in SEC Rule 144; 

(b) file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange
Act; and 
 (c) so long as a Holder owns any Restricted Securities, furnish to the Holder forthwith upon request a written statement by the
Company as to its compliance with the reporting requirements of SEC Rule 144 and of any other reporting requirements of the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements), a copy of the
most recent annual or quarterly report of the Company, and such other reports and documents of the Company and other information in the possession of or reasonably obtainable by the Company as a Holder may reasonably request in availing itself of
any rule or regulation of the SEC allowing a Holder to sell any such securities without registration. 
 2.10 Termination of Registration
Rights. The rights and obligations of any Holder under this Agreement shall terminate when all shares of such Holder’s that were Registrable Securities cease to be Registrable Securities, provided that the indemnification provisions of
Subsection 2.8 shall survive such termination. This Agreement shall terminate at such time when there are no Registrable Securities outstanding, provided that the indemnification provisions of Subsection 2.8 shall survive such
termination. 

  
 13 

 3. MISCELLANEOUS.  

3.1 Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of
each of the parties and shall inure to the benefit of the Holder. The rights of the Holder hereunder, including the right to have the Company register Registrable Securities pursuant to this Agreement, may be assigned by the Holder (i) at any
time, to an Affiliate of the Holder or (ii) subject to transfer restrictions set forth in the Purchase Agreement, to any third party in connection with a transfer of Registrable Securities; but only if such transferee executes a Joinder in the
form attached as Exhibit B hereto. Nothing herein shall be deemed to permit any assignment, transfer or other disposition of Registrable Securities in violation of the terms of applicable law and any applicable agreement. If any transferee of
any Holder shall acquire Registrable Securities, in any manner, whether by operation of law or otherwise, such Registrable Securities shall be held subject to and benefit from all of the terms of this Agreement, and by taking and holding such
Registrable Securities, such person shall be conclusively deemed to have agreed to be bound by and to perform all of the terms and provisions of this Agreement and such person shall be entitled to receive the benefits hereof. 

3.2 Compensation for Failure to Maintain Effective Registration Statement. In the event that (i) the Shelf Registration Statement
described in Section 2.1(a) covering (a) the Initial Shares is not effective on or before the 100th day after the Initial Closing Date or (b) the Subsequent Shares is not effective
on or before the 100th day after the Subsequent Closing Date or (ii) the Company fails to keep the Shelf Registration Statement effective during the Effective Period (any such failure being
referred to as an “Event”, and for purposes of clauses (i) and (ii), the date on which such Event occurs being referred to as “Event Date”), on each such Event Date and on each monthly anniversary of each such
Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to 1.0% of the
aggregate purchase price paid by such Holder pursuant to the Purchase Agreement for any unregistered Registrable Securities then held by such Holder. The parties agree that the maximum aggregate liquidated damages payable to a Holder under this
Agreement shall be 5.0% of the aggregate purchase price paid by such Holder for its Registrable Securities. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including,
without limitation, a decree of specific performance and/or injunctive relief. 
 3.3 Governing Law. This Agreement shall be governed
by the substantive laws of the State of California, U.S.A., without regard to its or any other jurisdiction’s choice of law rules. 

3.4 Jurisdiction. Any and all disputes arising out of, concerning, or related to this Agreement, or to the interpretation, performance,
breach or termination thereof shall be referred to and resolved by arbitration administered in the City and County of San Francisco, California, in accordance with the then current Comprehensive Arbitration Rules and Procedures of the Judicial
Arbitration and Mediation Services, Inc. (“JAMS”), or its successor, and judgment upon the award rendered may be entered in any court having jurisdiction thereof. Such arbitration shall be conducted by a single arbitrator appointed
by JAMS in accordance with its rules. The decision of the arbitrator as to any claim or dispute shall be final, binding, and conclusive upon the parties. Such decision shall be written and shall be supported by written findings of fact and
conclusions which shall set forth the award, judgment, decree or order awarded by the arbitrator. In the event that recourse to the courts shall be necessary for the purpose of determining any question of law required to be determined for
arbitration or for interim or conservatory relief, including a temporary restriction order or preliminary injunction (as necessary), the parties hereto hereby submit to the exclusive jurisdiction of the state and federal courts of San Francisco,
California, agree not to commence any suit, action or proceeding relating thereto except in such courts, and waive, to the fullest extent permitted by law, the right to move to dismiss or transfer any action brought in such courts on the basis of
any objection to personal jurisdiction or venue. 

  
 14 

 3.5 Waiver of Jury Trial. EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM
OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, THE REGISTRABLE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE
ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING
NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER
WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL. 

3.6 Counterparts. This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature) or other transmission method and any counterpart so delivered shall be
deemed to have been duly and validly delivered and be valid and effective for all purposes.
 3.7 Titles and Subtitles. The titles and
subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement. 
 3.8
Notices. All notices, requests, consents and other communications hereunder shall be in writing, shall be sent by confirmed facsimile, electronic mail, first-class registered or certified airmail, or nationally recognized overnight express
courier, postage prepaid, and shall be deemed given when so sent in the case of facsimile or electronic mail, or when so received in the case of mail or courier, and addressed as follows: 

if to the Company, to: 

Coherus Biosciences, Inc. 

333 Twin Dolphin Dr., Suite 600 

Redwood City, CA, USA 94065 

Attn:    ############# ##### 

Email: ############## 

with a copy to (which shall not constitute notice): 

Latham & Watkins LLP 

140 Scott Drive 

Menlo Park, California 94025 

Telephone No.: (650) 328-4600 

Facsimile No.: (650) 463-2600 

Attention: Alan C. Mendelson 

  
 15 

 if to the Purchaser, to: 

V-Sciences Investments Pte Ltd 

60B Orchard Road #06-18 

Tower 2, The Atrium@Orchard 

Singapore 238891 

Attention: #### #### 

Email: ############## 

with a copy to (which shall not constitute notice): 

Morrison & Foerster LLP 

San Francisco, California 94105 

Attn: Alfredo B. D. Silva, Esq. 

          John M. Rafferty, Esq. 

Fax: (415) 268-7522 

Email: asilva@mofo.com 

            jrafferty@mofo.com 

or such other address as may be designated in writing hereafter, in the same manner, by such Person; and 

if to any other Person who is then the registered Holder, to the address of such Holder as it appears in the stock transfer books of the
Company, or to such other place as such Holder shall designate to the Company in writing. 
 3.9 Amendments and Waivers. This
Agreement may be amended with the consent of the Company and the Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company shall have obtained a written consent to such
amendment, action or omission to act of the Holders of at least a majority of the Registrable Securities, provided however, that any modification, alteration, waiver or change that has a disproportionate and adverse effect on any right of any Holder
shall not be effective against such Holder without the prior written consent of such Holder. 
 No waiver of any terms or conditions of this
Agreement shall operate as a waiver of any other breach of such terms and conditions or any other term or condition, nor shall any failure to enforce any provision hereof operate as a waiver of such provision or of any other provision hereof. No
written waiver hereunder, unless it by its own terms explicitly provides to the contrary, shall be construed to effect a continuing waiver of the provisions being waived and no such waiver in any instance shall constitute a waiver in any other
instance or for any other purpose or impair the right of the party against whom such waiver is claimed in all other instances or for all other purposes to require full compliance with such provision. The failure of any party to enforce any provision
of this Agreement shall not be construed as a waiver of such provision and shall not affect the right of such party thereafter to enforce each provision of this Agreement in accordance with its terms. 

  
 16 

 3.10 Severability. In case any one or more of the provisions contained in this Agreement
is for any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such invalid, illegal, or unenforceable provision shall be
reformed and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law 
 3.11 Other
Agreements. The Company shall not hereafter enter into any agreement with respect to its securities which is inconsistent with or violates the rights granted to the holders of Registrable Securities in this Agreement, and to the extent the
Company grants any future holder rights with respect to registration of securities that are more favorable to such holders than the rights to the Holders under this Agreement, such more favorable rights shall apply to the Holders as well. 

3.13 Entire Agreement. This Agreement (including any Schedules and Exhibits hereto) constitutes the full and entire understanding and
agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly canceled. 

[Remainder of Page Intentionally Left Blank] 

  
 17 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their
duly authorized representatives as of the date first written above. 
  

			
	COMPANY:
	
	COHERUS BIOSCIENCES, INC.
		
	By:	 	 /s/ Dennis M. Lanfear

	Name:	 	Dennis M. Lanfear
	Title:	 	Chief Executive Officer

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their
duly authorized representatives as of the date first written above. 
  

			
	PURCHASER:
	
	V-SCIENCES INVESTMENTS PTE LTD
		
	By:	 	 /s/ Khoo Shih

	Name:	 	Khoo Shih
	Title:	 	Authorized Signatory

 [Signature Page to Registration Rights Agreement] 

 EXHIBIT A 

PLAN OF DISTRIBUTION  

We are registering the shares of common stock issued to the selling stockholder to permit the resale of these shares of common stock by the
holder of the shares of common stock from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the selling stockholder of the shares of common stock. We will bear all fees and expenses incident to
our obligation to register the shares of common stock. 
 The selling stockholder and any of its transferees, donees, pledgees or other
successors in interest may, from time to time, sell all or a portion of the shares of common stock beneficially owned by the selling stockholder and offered hereby from time to time directly or through one or more underwriters, broker-dealers or
agents. If the shares of common stock are sold through underwriters or broker-dealers, the selling stockholder will be responsible for underwriting discounts or commissions or agent’s commissions. The shares of common stock may be sold on any
national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale, in the over-the-counter market or in transactions
otherwise than on these exchanges or systems or in the over-the-counter market and in one or more transactions at fixed prices, at prevailing market prices at the time
of the sale, at varying prices determined at the time of sale, or at negotiated prices. These sales may be effected in transactions, which may involve crosses or block transactions. The selling stockholder may use any one or more of the following
methods when selling shares: 
  

	 	•	ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; 

  

	 	•	block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction; 

 

	 	•	purchases by a broker-dealer as principal and resale by the broker-dealer for its account; 

  

	 	•	an exchange distribution in accordance with the rules of the applicable exchange; 

  

	 	•	privately negotiated transactions; 

  

	 	•	settlement of short sales entered into after the effective date of the registration statement of which this prospectus is a part; 

  

	 	•	in transactions through broker-dealers that agree with the selling stockholder to sell a specified number of such shares at a stipulated price per share; 

 

	 	•	through the writing or settlement of options or other hedging transactions, whether such options are listed on an options exchange or otherwise; 

 

	 	•	through one or more underwritten offerings on a firm commitment or best efforts basis; 

  

	 	•	a combination of any such methods of sale; and 

  

	 	•	any other method permitted pursuant to applicable law. 

 The selling stockholder also may resell all or a portion of the shares in open market
transactions in reliance upon Rule 144 under the Securities Act, as permitted by that rule, or Section 4(a)(1) under the Securities Act, if available, rather than under this prospectus, provided that the selling stockholder meets the
criteria and conforms to the requirements of those provisions. 
 Broker-dealers engaged by the selling stockholder may arrange for other
broker-dealers to participate in sales. If the selling stockholder effects such transactions by selling shares of common stock to or through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents may receive commissions
in the form of discounts, concessions or commissions from the selling stockholder or commissions from purchasers of the shares of common stock for whom they may act as agent or to whom they may sell as principal. Such commissions will be in amounts
to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction will not be in excess of a customary brokerage commission in compliance with FINRA Rule 2121 (and any successor); and in the
case of a principal transaction a markup or markdown in compliance with FINRA 2121. 
 In connection with sales of the shares of common
stock or otherwise, the selling stockholder may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the shares of common stock in the course of hedging in positions they
assume. The selling stockholder may also sell shares of common stock short and if such short sale shall take place after the date that the registration statement of which this prospectus is a part is declared effective by the Commission, the selling
stockholder may deliver shares of common stock covered by this prospectus to close out short positions and to return borrowed shares in connection with such short sales. The selling stockholder may also loan or pledge shares of common stock to
broker-dealers that in turn may sell such shares, to the extent permitted by applicable law. The selling stockholder may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more
derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as
supplemented or amended to reflect such transaction). [Notwithstanding the foregoing, the selling stockholder has been advised that the selling stockholder may not use shares registered on the registration statement of which this prospectus forms a
part to cover short sales of our common stock made prior to the date the registration statement, of which this prospectus forms a part, has been declared effective by the Commission.]1 

The selling stockholder may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by the
selling stockholder and, if the selling stockholder defaults in the performance of its secured obligations, the pledgees or secured parties may offer and sell the shares of common stock from time to time pursuant to this prospectus or any amendment
to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act, as amended, amending, if necessary, the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling
stockholders under this prospectus. The selling stockholder also may transfer and donate the shares of common stock in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial
owners for purposes of this prospectus. 
  

	1 	To be removed if on Form S-3ASR. 

 The selling stockholder and any broker-dealer or agents participating in the distribution of the
shares of common stock may be deemed to be “underwriters” within the meaning of Section 2(11) of the Securities Act in connection with such sales. In such event, any commissions paid, or any discounts or concessions allowed to, any
such broker-dealer or agent and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. If the selling stockholder is deemed to be an “underwriter” within
the meaning of Section 2(11) of the Securities Act, it will be subject to the applicable prospectus delivery requirements of the Securities Act and may be subject to certain statutory liabilities of, including but not limited to,
Sections 11, 12 and 17 of the Securities Act and Rule 10b-5 under the Securities Exchange Act of 1934, as amended, or the Exchange Act. 

The selling stockholder has informed us that it is not a registered broker-dealer and does not have any written or oral agreement or
understanding, directly or indirectly, with any person to distribute the common stock. Upon our being notified in writing by the selling stockholder that any material arrangement has been entered into with a broker-dealer for the sale of common
stock through a block trade, special offering, exchange distribution or secondary distribution or a purchase by a broker-dealer, a supplement to this prospectus will be filed, if required, pursuant to Rule 424(b) under the Securities Act,
disclosing: 
  

	 	•	the name of the selling stockholder and of the participating broker-dealer(s), 

  

	 	•	the number of shares involved, 

  

	 	•	the price at which such the shares of common stock were sold, 

  

	 	•	the commissions paid or discounts or concessions allowed to such broker-dealer(s), where applicable, 

  

	 	•	that such broker-dealer(s) did not conduct any investigation to verify the information set out or incorporated by reference in this prospectus, and 

 

	 	•	other facts material to the transaction. 

 In no event shall any broker-dealer receive fees,
commissions and markups, which, in the aggregate, would exceed eight percent (8%). 
 Under the securities laws of some states, the shares
of common stock may be sold in such states only through registered or licensed brokers or dealers. In addition, in some states the shares of common stock may not be sold unless such shares have been registered or qualified for sale in such state or
an exemption from registration or qualification is available and is complied with. 
 There can be no assurance that the selling stockholder
will sell any or all of the shares of common stock registered pursuant to the registration statement, of which this prospectus forms a part. 

 The selling stockholder and any other person participating in such distribution will be subject
to applicable provisions of the Exchange Act, as amended, and the rules and regulations thereunder, including, without limitation, Regulation M of the Exchange Act, which may limit the timing of purchases and sales of any of the shares of
common stock by the selling stockholder and any other participating person. Regulation M may also restrict the ability of any person engaged in the distribution of the shares of common stock to engage in market-making activities with respect to
the shares of common stock. All of the foregoing may affect the marketability of the shares of common stock and the ability of any person or entity to engage in market-making activities with respect to the shares of common stock. 

We will pay all expenses of the registration of the shares of common stock pursuant to the registration rights agreement, including, without
limitation, Securities and Exchange Commission filing fees and expenses of compliance with state securities or “blue sky” laws; provided, however, that the selling stockholder will pay all underwriting discounts and selling
commissions, if any. We will indemnify the selling stockholder against certain liabilities, including some liabilities under the Securities Act, in accordance with a registration rights agreement, or the selling stockholder will be entitled to
contribution. We may be indemnified by the selling stockholder against civil liabilities, including liabilities under the Securities Act, that may arise from any written information furnished to us by the selling stockholder specifically for use in
this prospectus, in accordance with the related registration rights agreements, or we may be entitled to contribution. 
 To the extent
required, this prospectus may be amended and/or supplemented from time to time to describe a specific plan of distribution. 

 EXHIBIT B 

FORM OF JOINDER 
 THIS JOINDER is made on this
[•] day of [•], 20[•]
 BETWEEN 
 (1) (the
“New Party”); 
 AND 
 (2) V-SCIENCES INVESTMENTS PTE LTD (the “Current Party”); 
 AND 

(3) COHERUS BIOSCIENCES, INC., (the “Company”). 

WHEREAS a Registration Rights Agreement was entered into on [•], 2017 by and among, inter alia, the Current Party and the Company (the “Registration
Rights Agreement”), a copy of which the New Party hereby confirms that it has been supplied with and acknowledges the terms therein. 
 NOW IT IS
AGREED as follows: 
 1. In this Joinder, unless the context otherwise requires, words and expressions respectively defined or construed in
the Registration Rights Agreement shall have the same meanings when used or referred to herein. 
 2. The New Party hereby accedes to and
ratifies the Registration Rights Agreement and covenants and agrees with the Current Party and the Company to be bound by the terms of the Registration Rights Agreement as a “Purchaser” and to duly and punctually perform and discharge all
liabilities and obligations whatsoever from time to time to be performed or discharged by it under or by virtue of the Registration Rights Agreement in all respects as if named as a party therein. 

3. The Company covenants and agrees that the New Party shall be entitled to all the benefits of the terms and conditions of the Registration
Rights Agreement to the intent and effect that the New Party shall be deemed, with effect from the date on which the New Party executes this Joinder, to be a party to the Registration Rights Agreement as a “Purchaser.” 

4. This Joinder shall hereafter be read and construed in conjunction and as one document with the Registration Rights Agreement and references
in the Registration Rights Agreement to “the Agreement” or “this Agreement,” and references in all other instruments and documents executed thereunder or pursuant thereto to the Registration Rights Agreement, shall for all
purposes refer to the Registration Rights Agreement incorporating and as supplemented by this Joinder. 

 5. THIS JOINDER SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
CALIFORNIA, WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. 
 6. Any action or proceeding against any party hereto relating in
any way to this Joinder or the transactions contemplated hereby may be brought and enforced in any United States federal court or California State Court located in the County of San Mateo, California, and each party, on behalf of itself and its
respective successors and assigns, irrevocably consents to the jurisdiction of each such court in respect of any such action or proceeding. Each party, on behalf of itself and its respective successors and assigns, irrevocably consents to the
service of process in any such action or proceeding by the mailing of copies thereof by registered or certified mail, postage prepaid, return receipt requested, to such person or entity at the address for such person or entity set forth in
Section 3.8 of the Registration Rights Agreement or such other address such person or entity shall notify the other in writing. The foregoing shall not limit the right of any person or entity to serve process in any other manner permitted by
law or to bring any action or proceeding, or to obtain execution of any judgment, in any other jurisdiction. 
 7. Each party, on behalf of
itself and its respective successors and assigns, hereby irrevocably waives any objection that it may now or hereafter have to the laying of venue of any action or proceeding arising under or relating to this Joinder or the transactions contemplated
hereby in any court located in the County of San Mateo, California. Each party, on behalf of itself and its respective successors and assigns, hereby irrevocably waives any claim that a court located in the State of California is not a convenient
forum for any such action or proceeding. 
 8. Each party, on behalf of itself and its respective successors and assigns, hereby irrevocably
waives, to the fullest extent permitted by applicable United States federal and state law, all immunity from jurisdiction, service of process, attachment (both before and after judgment) and execution to which he might otherwise be entitled in any
action or proceeding relating in any way to this Joinder or the transactions contemplated hereby in the courts of the State of California, of the United States or of any other country or jurisdiction, and hereby waives any right he might otherwise
have to raise or claim or cause to be pleaded any such immunity at or in respect of any such action or proceeding. 
 9. The address of the
undersigned for purposes of all notices under the Registration Rights Agreement is set forth below. 
  

			
	 [NEW PARTY]

		
	 By:
	 	  

	 Name:
	 	  

	 Title:
	 	  

	 Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}]]